Alex Agelidis, MD, PhD

Alex Agelidis, MD, PhD

University of Illinois at Chicago

H-index: 17

North America-United States

About Alex Agelidis, MD, PhD

Alex Agelidis, MD, PhD, With an exceptional h-index of 17 and a recent h-index of 16 (since 2020), a distinguished researcher at University of Illinois at Chicago, specializes in the field of Immunology, Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Enhancement of antiviral drug efficacy through multimodal mechanism of Au nanoparticles decorated ZnO tetrapods

Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients

Intrinsic antiviral activity of optineurin prevents hyperproliferation of a primary herpes simplex virus type 2 infection

Role of Heparanase in Herpes Simplex Virus Pathogenesis

Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies

Optineurin is a novel host defense factor against viral infections of the eye and infection-associated nerve damage

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival

Alex Agelidis, MD, PhD Information

University

Position

MD/PhD Candidate -

Citations(all)

1567

Citations(since 2020)

1217

Cited By

792

hIndex(all)

17

hIndex(since 2020)

16

i10Index(all)

20

i10Index(since 2020)

19

Email

University Profile Page

University of Illinois at Chicago

Google Scholar

View Google Scholar Profile

Alex Agelidis, MD, PhD Skills & Research Interests

Immunology

Oncology

Top articles of Alex Agelidis, MD, PhD

Title

Journal

Author(s)

Publication Date

Enhancement of antiviral drug efficacy through multimodal mechanism of Au nanoparticles decorated ZnO tetrapods

Rahul K Suryawanshi

Chandrashekhar D Patil

Lulia Koujah

Pritam Kumar Panda

Sudhanshu Kumar Singh

...

2023

Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction

Science Advances

Rahul K Suryawanshi

Chandrashekhar D Patil

Alex Agelidis

Raghuram Koganti

Tejabhiram Yadavalli

...

2023/4/28

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients

Cancer medicine

Gregory P Botta

Tridu R Huynh

Samantha R Spierling‐Bagsic

Alexander Agelidis

Randolph Schaffer

...

2023/4

Intrinsic antiviral activity of optineurin prevents hyperproliferation of a primary herpes simplex virus type 2 infection

The Journal of Immunology

Chandrashekhar D Patil

Rahul Suryawanshi

Joshua Ames

Raghuram Koganti

Alex Agelidis

...

2022/1/1

Role of Heparanase in Herpes Simplex Virus Pathogenesis

Alexander Agelidis

2021

Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies

The ocular surface

Lulia Koujah

Mowafak Allaham

Chandrashekhar D Patil

Joshua M Ames

Rahul K Suryawanshi

...

2021/7/1

Optineurin is a novel host defense factor against viral infections of the eye and infection-associated nerve damage

Investigative Ophthalmology & Visual Science

Deepak Shukla

Joshua Ames

Tejabhiram Yadavalli

Rahul K Suryawanshi

James Hopkins

...

2021/6/21

Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival

JCI insight

Alex Agelidis

Benjamin A Turturice

Rahul K Suryawanshi

Tejabhiram Yadavalli

Dinesh Jaishankar

...

2021/4/4

Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection

MBio

Lulia Koujah

Krishnaraju Madavaraju

Alex M Agelidis

Chandrashekhar D Patil

Deepak Shukla

2021/12/21

Dissociation of DNA damage sensing by endoglycosidase HPSE

Iscience

Alex Agelidis

Rahul K Suryawanshi

Chandrashekhar D Patil

Anaamika Campeau

David J Gonzalez

...

2021/3/19

mTORC2 confers neuroprotection and potentiates immunity during virus infection

Nature communications

Rahul K Suryawanshi

Chandrashekhar D Patil

Alex Agelidis

Raghuram Koganti

Joshua M Ames

...

2021/10/14

Dysregulation of cell signaling by SARS-CoV-2

Rahul K Suryawanshi

Raghuram Koganti

Alex Agelidis

Chandrashekhar D Patil

Deepak Shukla

2021/3/1

OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection

Nature communications

Joshua Ames

Tejabhiram Yadavalli

Rahul Suryawanshi

James Hopkins

Alexander Agelidis

...

2021/9/13

Heparanase-regulated syndecan-1 shedding facilitates herpes simplex virus 1 egress

Journal of Virology

Satvik Hadigal

Raghuram Koganti

Tejabhiram Yadavalli

Alex Agelidis

Rahul Suryawanshi

...

2020/2/28

Heparanase, heparan sulfate and viral infection

Alex Agelidis

Deepak Shukla

2020

Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing

Science Advances

Tejabhiram Yadavalli

Rahul Suryawanshi

Raghuram Koganti

James Hopkins

Joshua Ames

...

2020/12/4

mTORC2 combats cellular stress and potentiates immunity during viral infection

bioRxiv

Rahul K Suryawanshi

Chandrashekhar D Patil

Alex Agelidis

Raghuram Koganti

Joshua M Ames

...

2020/10/10

Bacterial pigment prodigiosin demonstrates a unique antiherpesvirus activity that is mediated through inhibition of prosurvival signal transducers

Journal of Virology

Rahul K Suryawanshi

Lulia Koujah

Chandrashekhar D Patil

Joshua M Ames

Alex Agelidis

...

2020/6/16

Streptococcus Constellatus and Actinomyces Brain Abscess Without Signs of Contiguous Spread: A Case Report (725)

Neurology

Rahim Shakoor

Alexander Agelidis

Muhammad Waleed Zeb

Ahmed Hassan

2020/4/14

See List of Professors in Alex Agelidis, MD, PhD University(University of Illinois at Chicago)